Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis

This study has been completed.
Sponsor:
Information provided by:
Nabi Biopharmaceuticals
ClinicalTrials.gov Identifier:
NCT00071214
First received: October 15, 2003
Last updated: July 7, 2006
Last verified: July 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2005
  Estimated Primary Completion Date: No date given
No publications provided by Nabi Biopharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):